SPS
SLDB icon

Susquehanna Portfolio Strategies’s Solid Biosciences SLDB Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.07M Sell
107,279
-90,292
-46% -$685K 0.02% 550
2026
Q1 		$1.42M Sell
197,571
-1,865
-0.9% -$12K 0.02% 570
2025
Q4 		$1.12M Hold
199,436
– – 0.02% 624
2025
Q3 		$1.23M Hold
199,436
– – 0.02% 630
2025
Q2 		$971K Buy
199,436
+183,140
+1,124% +$647K 0.02% 511
2025
Q1 		$60.3K Buy
+16,296
New +$69.8K 0.03% 157

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Susquehanna Portfolio Strategies's SLDB Position: Q2 2026 in Review

Susquehanna Portfolio Strategies reduced its Solid Biosciences (SLDB) stake by 46% in Q2 2026, selling an estimated $685K and leaving 107,279 shares worth $1.07M. The position accounts for 0.02% of the portfolio, ranked #550.

Susquehanna Portfolio Strategies first reported a position in SLDB in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.42M in Q1 2026. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • Susquehanna Portfolio Strategies held 107,279 shares of Solid Biosciences worth $1.07M as of Q2 2026.
  • Susquehanna Portfolio Strategies sold 90,292 Solid Biosciences shares in Q2 2026, an estimated $685K.
  • Solid Biosciences made up 0.02% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #550 holding.
  • Susquehanna Portfolio Strategies first reported a position in Solid Biosciences in Q1 2025 and has held it in 6 quarters since.
  • Susquehanna Portfolio Strategies's Solid Biosciences position peaked at $1.42M in Q1 2026.
  • 157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.